Abstract
Allergen specific immunotherapy (ASIT) has been used for 100 years with efficacy confirmed of Subcutaneous Allergen Immunotherapy (SCIT) seen in numerous double-blind placebo controlled studies but recent evidence notes efficacy of sublingual immunotherapy (SLIT) which may be better tolerated than SCIT. This study assesses the efficacy and tolerability of both SCIT and SLIT in clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
